Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Thomas Andrew Crockett Insider Profile
11 Followers
Thomas Andrew Crockett, CEO, Director at KalVista Pharmaceuticals, holds 211.20K shares in KalVista Pharmaceuticals (Ticker: KALV).
Thomas Andrew Crockett has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Thomas Andrew Crockett's holdings
Insider Roles
CEO, Director
Roles that Thomas Andrew Crockett holds in companies
Most Profitable Insider Trade
The most profitable trade made by Thomas Andrew Crockett
Thomas Andrew Crockett's Trading History
List of latest transactions for each holding click on a transaction to see Thomas Andrew Crockett's performance on stock
You May Also Like
Thomas Andrew Crockett insider profile FAQ
What is the percentage of profitable transactions made by Thomas Andrew Crockett?
The percentage of profitable transactions made by Thomas Andrew Crockett is ―.
What is the average return per transaction made by Thomas Andrew Crockett?
The average return per transaction made by Thomas Andrew Crockett is ―.
What stocks does Thomas Andrew Crockett hold?
Thomas Andrew Crockett holds: KALV stocks.
What was Thomas Andrew Crockett’s latest transaction?
Thomas Andrew Crockett latest transaction was an Uninformative Buy of $438.77K.
What was Thomas Andrew Crockett's most profitable transaction?
Thomas Andrew Crockett’s most profitable transaction was an Informative Sell of KALV stock on February 16, 2024. The return on the trade was 19.20%.
What is Thomas Andrew Crockett's role in KalVista Pharmaceuticals?
Thomas Andrew Crockett's role in KalVista Pharmaceuticals is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.